Ashkan Emadi, Alexander Bland Osborn Endowed Chair and Distinguished Professor of Medical Oncology at West Virginia University Cancer Institute, shared a post on LinkedIn:
“I am honored to be invited to deliver a Scientific Workshop at the American Society of Hematology meeting titled “Cutting Glutamine, Halting Translation: A Metabolic Therapy in Blood Cancer.”
This talk will explore how targeting glutamine metabolism can suppress protein translation in malignant cells—a potential therapeutic strategy that may reshape how we approach blood cancers.
Check out the schedule here.
I’m grateful to my colleagues and collaborators for their partnership and dedication to advancing discovery and improving outcomes for patients.”
More posts on OncoDaily.